,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #efje ,,in ,,the ,,house ,,of ,,representatives ,april #bd1 #bjah ,mr4 ,ruiz introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to provide for an opioid use disorder treatment demonstration program4 #a4 ,short title ,this ,act may be cited as the ,advancing ,high ,quality ,treatment for ,opioid ,use ,disorders in ,medicare ,act4 #b4 ,opioid use disorder treatment demonstration program ,title ,,xviii of the ,social ,security ,act 7#db ,u4,s4,c4 #acie et seq47 is amended by inserting after section #ahff;,e 7#db ,u4,s4,c4 #acie;cc-#e7 the following new section3 #ahff;,f4 ,opioid use disorder treatment demonstration program 7a7 ,implementation of #e-,year demonstration program 7#a7 ,in general ,not later than ,january #a1 #bjba1 the ,secretary shall implement a #e-year demonstration program under this title 7in this section referred to as the ,program7 to increase access of applicable beneficiaries to opioid use disorder treatment services1 improve physical and mental health outcomes for such beneficiaries1 and to the extent possible1 reduce expenditures under this title4 ,under the ,program1 the ,secretary shall make payments under subsection 7f7 to participating care teams 7as defined in subsection 7c77#a77;,a77 for providing opioid use disorder treatment services to applicable beneficiaries participating under the ,program4 7#b7 ,opioid use disorder treatment services ,for purposes of this section1 the term opioid use disorder treatment services-- 7,a7 means1 with respect to an applicable beneficiary1 services that are furnished for the treatment of opioid use disorders in an outpatient setting and-- 7i7 which are supported by the per applicable beneficiary per month care management fee under subsection 7f72 or 7ii7 for which payment may otherwise be made under this title2 and 7,b7 includes-- 7i7 medication assisted treatment2 7ii7 treatment planning2 7iii7 appropriate outpatient psychiatric1 psychological1 or counseling services 7or any combination of such services72 7iv7 appropriate social support services2 and 7v7 care management and care coordination of opioid use disorder services1 as well as coordination with other physicians and providers treating the mental and physical conditions of such beneficiary4 7b7 ,program design 7#a7 ,in general ,the ,secretary shall design the ,program in such a manner to evaluate the extent to which the ,program accomplishes the following purposes3 7,a7 ,reduces hospitalizations and emergency department visits4 7,b7 ,reduces the occurrence of overdoses from opioids1 including prescription opioid medications as well as illicit opioids4 7,c7 ,increases use of medication-assisted treatment for opioid use disorders4 7,d7 ,improves health outcomes of individuals with opioid use disorders1 including by reducing the incidence of infectious diseases 7such as hepatitis ,c and ,,hiv74 7,e7 ,does not increase the total spending on health care services under this title4 7,f7 ,reduces deaths from opioid poisoning4 7,g7 ,reduces the utilization of inpatient residential treatment4 7#b7 ,consultation ,in designing the ,program1 the ,secretary shall1 not later than #c months after the date of the enactment of this section1 consult with specialists in the field of addiction and clinicians in the primary care community4 7c7 ,participating care teams 7#a7 ,definition2 selection 7,a7 ,definition ,in this section1 the term participating care team means an opioid use disorder care team 7as defined in paragraph 7#b77 that is participating under the ,program pursuant to selection by the ,secretary under subparagraph 7,b74 7,b7 ,selection ,under the ,program1 the ,secretary shall provide for a process for opioid use disorder care teams to apply for participation under the ,program as participating care teams and for selecting such teams for such participation4 7,c7 ,preference ,in selecting opioid use disorder care teams under subparagraph 7,b7 for participation under the ,program1 the ,secretary shall give preference to opioid use disorder care teams that are located in areas with a prevalence of opioid use disorders that is higher than the national average prevalence1 as measured by aggregate overdoses of opioids1 or any other measure that the ,secretary deems appropriate4 7#b7 ,opioid use disorder care teams 7,a7 ,in general ,for purposes of this section1 the term opioid use disorder care team means a group of health care practitioners1 or an entity employing or contracting with such health care practitioners1 that-- 7i7 includes at least one physician who is providing primary care services or addiction treatment services to an applicable beneficiary during the period in which the opioid use disorder care team is receiving payments under subsection 7f72 7ii7 includes at least one eligible practitioner 7as defined in paragraph 7#c77;,a771 who may be a physician who meets the criterion in clause 7i72 and 7iii7 includes other practitioners-- 7,i7 as necessary to deliver appropriate psychiatric1 psychological1 counseling1 and social services to applicable beneficiaries in addition to the services delivered by the eligible practitioner2 and 7,,ii7 who only perform services that such practitioners are legally authorized to perform under ,state law4 7,b7 ,requirements for participation ,in order for an opioid use disorder care team to participate in the ,program as a participating care team1 each of the practitioners participating on the team shall agree to-- 7i7 deliver opioid use disorder treatment services to applicable beneficiaries who agree to receive the services2 7ii7 meet minimum standards for quality required by the ,program2 and 7iii7 submit to the ,secretary1 with respect to each applicable beneficiary for whom such practitioner provides opioid use disorder treatment services1 data with respect to the quality standards and the measures defined in subsection 7d7 and such other information as the ,secretary determines appropriate to monitor and evaluate the ,program and to determine the performance of each practitioner for purposes of the incentive payment under subsection 7f71 in such form1 manner1 and frequency as specified by the ,secretary4 7#c7 ,eligible practitioners2 ,other provider-related definitions and application provisions 7,a7 ,eligible practitioners ,for purposes of this section1 the term eligible practitioner means1 with respect to an applicable beneficiary1 a provider of services that-- 7i7 participates in the ,medicare program under this title2 7ii7 7,i7 is authorized to prescribe or dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment2 and 7,,ii7 has in effect a registration or waiver in accordance with section #cjc7;g7 of the ,controlled ,substances ,act for such purpose and is otherwise in compliance with regulations promulgated by the ,substance ,abuse and ,mental ,health ,services ,administration to carry out such section2 and 7iii7 with respect to furnishing opioid use disorder treatment services to the applicable beneficiary1 participates in an opioid use disorder care team1 which is a participating care team4 7,b7 ,addiction specialists ,for purposes of paragraph 7#b77;,c71 the term addiction specialist means a physician that possesses expert knowledge and skills in addiction medicine1 as evidenced by-- 7i7 certification by the ,american ,society of ,addiction ,medicine or the ,american ,board of ,addiction ,medicine2 7ii7 subspecialty certification in addiction medicine by the ,american ,board of ,preventive ,medicine2 7iii7 subspecialty certification in addiction psychiatry by the ,american ,board of ,psychiatry and ,neurology2 7iv7 a certificate of added qualification in addiction medicine conferred by the ,american ,osteopathic ,association2 or 7v7 completion of an accredited residency or fellowship in addiction medicine or addiction psychiatry4 7d7 ,quality and other reporting requirements 7#a7 ,adoption and development of standards and performance measures ,not later than #i months after the date of the enactment of this section1 the ,secretary1 in conjunction with stakeholders 7including clinicians in the primary care community and the field of addiction medicine71 shall adopt or develop 7or an appropriate entity with which the ,secretary contracts shall develop7 quality standards and methods of assessing the quality of care to ensure a minimum level of quality of care and to determine whether the services furnished by participating care teams are achieving the purposes described in subsection 7b77#a74 ,for purposes of adopting or developing standards for payments under subsection 7f77#a7 and for purposes of adopting or developing methods for assessing performance for the incentive payments under subsection 7f77#b71 the ,secretary may consider existing clinical guidelines for the treatment of opioid use disorders and standards or measures applied for use under the ,medicaid program under title ,,xix4 ,standards and assessment methods shall address the following outcomes and performance criteria3 7,a7 ,patient engagement in treatment4 7,b7 ,retention in treatment4 7,c7 ,provision of evidence-based medication-assisted treatment4 7,d7 ,any other criteria the ,secretary deems appropriate4 7#b7 ,submission ,each participating care team shall submit to the ,secretary1 in such form1 manner1 and frequency specified by the ,secretary1 data with respect to such standards and assessment methods and such other information as the ,secretary determines appropriate to monitor and evaluate the ,program and to determine the performance of such team for purposes of the incentive payment under subsection 7f77#b74 7e7 ,participation of applicable beneficiaries 7#a7 ,applicable beneficiary defined ,in this section1 the term applicable beneficiary means an individual who-- 7,a7 is entitled to benefits under part ,a and enrolled for benefits under part ,b2 7,b7 is not enrolled in a ,medicare ,advantage plan under part ,c2 7,c7 has a diagnosis for an opioid use disorder2 and 7,d7 meets such other criteria as the ,secretary determines appropriate4 ,such term shall include an individual who is dually eligible for benefits under this title and title ,,xix if such individual satisfies the criteria described in subparagraphs 7,a7 through 7,d74 7#b7 ,voluntary participation ,an applicable beneficiary may participate in the ,program on a voluntary basis and may terminate participation in the ,program at any time4 7#c7 ,services ,in order to participate in the ,program1 an applicable beneficiary must agree to receive opioid use disorder treatment services from a participating care team4 ,an applicable beneficiary may only receive services supported by the ,program from one participating care team during any one calendar month4 ,participation under the ,program shall not affect coverage of or payment for any other item or service under this title for the applicable beneficiary4 7#d7 ,beneficiary access to services ,nothing in this section shall be construed as encouraging providers to limit applicable beneficiary access to services covered under this title and applicable beneficiaries shall not be required to relinquish access to any benefit under this title as a condition of receiving services from a participating care team4 7f7 ,payments 7#a7 ,per applicable beneficiary per month care management fee 7,a7 ,in general ,the ,secretary shall establish a schedule of per applicable beneficiary per month care management fees4 ,such a per applicable beneficiary per month care management fee shall be paid to a participating care team in addition to any other amount otherwise payable under this title to the practitioners participating with the team or1 if applicable1 the entity with respect to such team employing or contracting with such practitioners4 ,a participating care team may use such per applicable beneficiary per month care management fee to deliver additional services to applicable beneficiaries1 including services not otherwise eligible for payment under this title4 7,b7 ,application ,in carrying out subparagraph 7,a71 the ,secretary shall-- 7i7 consider the costs that participating care teams are expected to incur in delivering high-quality opioid use disorder care services that are not covered by payments otherwise payable to the teams under this title2 7ii7 pay a higher per applicable beneficiary per month care management fee for an applicable beneficiary who receives more intensive treatment services from a participating care team and who is appropriate for such services based on clinical guidelines for opioid use disorder care2 7iii7 pay a higher per applicable beneficiary per month care management fee for the month in which the applicable beneficiary begins treatment with a participating care team than in subsequent months1 to reflect the greater time and costs required for the team to plan and initiate treatment1 as compared to maintenance of treatment2 and 7iv7 pay higher per applicable beneficiary per month care management fees for participating care teams that include an addiction specialist who is either delivering services directly to applicable beneficiaries or providing consulting support to those practitioners participating with such teams who are delivering services to applicable beneficiaries4 7#b7 ,incentive payments ,under the ,program1 the ,secretary shall establish a performance-based incentive payment1 which shall be paid to participating care teams based on the performance of such teams with respect to standards and assessment methods adopted or developed by the ,secretary under subsection 7d7 and with respect to which the teams report under such subsection4 7g7 ,multipayer strategy ,in carrying out the ,program1 the ,secretary shall encourage other payers to provide similar payments and to use similar quality standards and methods of assessment as applied under the ,program4 ,the ,secretary may enter into a memorandum of understanding with other payers to align the methodology for payment provided by such a payer related to opioid use disorder treatment services with such methodology for payment under the ,program4 7h7 ,evaluation 7#a7 ,in general ,the ,comptroller ,general of the ,united ,states shall conduct an intermediate and final evaluation of the program4 ,each such evaluation shall determine the extent to which each of the purposes described in subsection 7b7 have been accomplished under the ,program4 ,each evaluation shall also determine the extent to which the structure and requirements of the ,program facilitated or impeded the participation of practitioners in the program1 the participation of beneficiaries with opioid use disorder1 and the delivery of high-quality opioid use disorder treatment services4 7#b7 ,reports ,the ,comptroller ,general of the ,united ,states shall submit to the ,secretary and ,congress-- 7,a7 a report with respect to the intermediate evaluation under paragraph 7#a7 not later than #c years after the date of the implementation of the ,program2 and 7,b7 a report with respect to the final evaluation under paragraph 7#a7 not later than #f years after such date4 7i7 ,funding 7#a7 ,administrative funding ,for the purposes of implementing1 administering1 and carrying out the ,program 7other than for purposes described in paragraph 7#b771 there shall be transferred to the ,secretary for the ,center for ,medicare ,medicaid ,services ,program ,management ,account from the ,federal ,supplementary ,medical ,insurance ,trust ,fund under section #ahda #e1jjj1jjj4 7#b7 ,care management fees and incentives ,for the purposes of payments under subsection 7f71 there shall be transferred to the ,secretary such sums as are necessary from the ,federal ,supplementary ,medical ,insurance ,trust ,fund under section #ahda for each of fiscal years #bjba through #bjbe4 7#c7 ,availability ,amounts transferred under this subsection for a fiscal year shall be available until expended4 7j7 ,waivers ,the ,secretary may waive any provision of this title that conflicts with or impedes the implementation of the provisions of this section4 4